Results of longterm hospital based cytological screening in asymptomatic women

Diagnostic Cytopathology

Volumn 34, Issue 3, 2006, Pages 184-187

  Misra, Jata S ^a,b   Singh, Uma ^a  

^a UNIVERSITY OF LUCKNOW   (India)

^b NONE

Author keywords

Asymptomatic women; Carcinoma cervix; Cytological screening; Risk factors; SIL

Indexed keywords

ADULT; ARTICLE; CANCER CYTODIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CANDIDA ALBICANS; CYTOLOGY; FEMALE; FEMALE GENITAL TRACT INFECTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MARRIAGE; PARITY; PRIORITY JOURNAL; RELIGION; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; SOCIOECONOMICS; TRICHOMONAS VAGINALIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

ADULT; ANIMALS; CYTODIAGNOSIS; FEMALE; GENITAL DISEASES, FEMALE; GENITAL NEOPLASMS, FEMALE; HERPES SIMPLEX; HUMANS; INCIDENCE; INDIA; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATIENT EDUCATION; RISK FACTORS; SIMPLEXVIRUS; SOCIAL CLASS; TRICHOMONAS VAGINALIS; TRICHOMONAS VAGINITIS; UTERINE CERVICAL NEOPLASMS;

EID: 33644924879     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20377     Document Type: Article

References (18)

1. Perkin D. Estimates of the worldwide frequency of 16 major cancers in 1980. Int J Cancer 1988;41:184-197.
2. Christopherson WM, Parker C. Control of cervical cancer in women of low income in a community. Cancer 1969;24:64-69.
3. Cramer DW. Role of cervical cytology in declining morbidity and mortality of cervical cancer. Cancer 1974;34:2018-2027.
4. Johanneson G, Garisson G, Day N. The effect of mass screening in Iceland on the incidence on mortality of cervical carcinoma. Int J Cancer 1978;21:418-425.
5. Soost HJ, Bockmuhl B, Zock H. Results of cytological screening in the Federal Republic of Germany. Acta Cytol 1982;26:445-451.
6. Dowang Y, Jufany Y, Shoufu K. Mass cytological screening for cervical cancer in China. A review of 7,73,557 reported cases. Acta Cytol 1985;29:341-344.
7. World Health Organization. Cytology of the female genital tract. WHO, Geneva. 1973.
8. Bethasda system for reporting cervical vaginal cytological diagnosis. Acta Cytol 1995;37:115-120.
9. Misra JS, Das K, Chandrawati. Results of clinically downstaging cervical cancer in a cytological screening, programme. Diagn Cytopathol 1988;19:344-348.
10. Garud MA, Saraiya UB, Lutta M. Cytology screening programme in urban and rural community in India. Acta Cytol 1983;27;429-431.
11. Sadana S, Sodhani P, Agrawal SS, et al. Epidemiological analysis of Trichomonas Vaginalis infection in inflammatory smears. Acta Cytol 1994;38:687-690.
12. Lawson HW, Henson R, Kaeser MK. Implementing recommendation for early detection of breast and cervical cancer among low-income women. MMWR Recomm Rep 2000;49:37-55.
13. Deq Uadrons CA, Victoria CG, Costa JS. Coverage and focus of a cervical cancer prevention programme in Southern Brazil. Rev Panam Salud Publica 2004;16:225-232.
14. Loerzel VW, Bushy A. Interventions that address cancer health disparities in women. Fam Community Health 2005;28:79-89.
15. Pham McNeill JH. Cervical cancer among young Vietnamese American women: incidence, risk factors and early detection. Asian Am Pac Isl J Health 2003;10:100-107.
16. Hislop TG, Teh C, Lai A, Ralston JD, Shu J, Taylor VM. Pap screening and knowledge of risk factors for cervical cancer in Chinese women in British Columbia, Canada. Ethn Health 2004;9:267-281.
17. Behbakht K, Lynch A, Masad S. Social and cultural barriers in Papancalaou test screening in an urban population. Obstet Gynecol 2004;104:1355-13561.
18. Moore MA, Tajima K. Cervical cancer in the Asian Pacific-epidemiology, screening and treatment. Asian Pac J Cancer Prev 2004;5:349-361.